UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE13a-16 OR15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For June 13, 2018
Commission File Number:001-31368
SANOFI
(Translation of registrant’s name into English)
54, rue la Boétie, 75008 Paris, France
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under coverForm 20-F orForm 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting theForm 6-K in paper as permitted by RegulationS-T Rule 101(b)(1):
Yes ☐ No ☒
Indicate by check mark if the registrant is submitting theForm 6-K in paper as permitted by RegulationS-T Rule 101(b)(7):
Yes ☐ No ☒
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule12g3-2(b) under the Securities Exchange Act of 1934.
Yes ☐ No ☒
If “Yes” marked, indicate below the file number assigned to the registrant in connection with Rule12g3-2(b):82-
In June 2018, Sanofi issued the statement attached hereto as Exhibit 99.1 which is incorporated herein by reference.
Exhibit List
| | |
Exhibit No. | | Description |
| |
Exhibit 99.1 | | Press release dated June 13, 2018: Sanofi successfully prices USD 2 billion bond issue |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: June 13, 2018
| | |
SANOFI |
| |
By: | | /s/ Alexandra Roger |
Name: | | Alexandra Roger |
Title: | | Head of Securities Law and Capital Markets |
3
Exhibit Index
| | |
Exhibit No. | | Description |
| |
Exhibit 99.1 | | Press release dated June 13, 2018: Sanofi successfully prices USD 2 billion bond issue |
4